Arch Pharm Res. 2023 Jan;46(1):44-58.doi: 10.1007/s12272-023-01426-5. Epub 2023 Jan 6.
2023-01-23Arch Pharm Res. 2023 Jan;46(1):44-58.doi: 10.1007/s12272-023-01426-5. Epub 2023 Jan 6. MEKs/ERKs-mediated FBXO1/E2Fs interaction interference modulates G1/S cell cycle transition and cancer cell proliferation MEKs/ERKs介导的FBXO1/E2Fs相互作用干扰调节G1/S细胞周期转变和癌症细胞增殖